Erste Group downgraded UnitedHealth (UNH) to Hold from Buy. A recent civil investigation by the Department of Justice into the accuracy of patient billings covered by the Medicare Advantage Plan increases economic uncertainty for investors, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Senator Grassley probing UnitedHealth billing practices, WSJ reports
- UnitedHealth drops 1% to $454.01 after WSJ report of Grassley probe
- UnitedHealth price target lowered to $560 from $610 at Argus
- UnitedHealth’s Strategic Positioning and Valuation Justify Buy Rating Amid DOJ Scrutiny
- Morgan Stanley views move in UnitedHealth’s shares as ‘seemingly overdone’